Full Length Research Paper
References
Assoumou PA, Aki TM, Oussavou O, Mengome EM (2020). Clinical Characteristics of Nystagmus in Albinos Living in Libreville. Open Journal of Ophthalmology 10(1):69-76. |
|
Chaki M, Mukhopadhyay A, Ray K (2005). Determination of variants in the 3'-region of the tyrosinase gene requires locus specific amplification. Human Mutation 26(1):53-58. |
|
Chan HW, Schiff ER, Tailor VK, Malka S, Neveu MM, Theodorou M, Moosajee M (2021). Prospective Study of the Phenotypic and Mutational Spectrum of Ocular Albinism and Oculocutaneous Albinism. Genes 12(4):508 |
|
Christine FW, Peter JO, Simon C (2000). Albinism: Its Implications for Refractive Development. Investigative Ophthalmology and Visual Science 41(1):1-7. |
|
Dolinska MB, Kus NJ, Farney SK, Wingfield PT, Brooks BP, Sergeev YV (2017). Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity. Pigment Cell and Melanoma Research 30(1):41-52. |
|
Eballé AO, Mvogo CE, Noche C, Zoua ME, Dohvoma AV (2013). Refractive errors in Cameroonians diagnosed with complete oculocutaneous albinism. Clinical Ophthalmology 7:1491-1500 |
|
Enechukwu NA, Ogun GO, Ezejiofor OI, Chukwuanukwu TO, Yaria J, George AO, Ogunbiyi AO (2020). Histopathologic patterns of cutaneous malignancies in individuals with oculocutaneous albinism in Anambra state, Nigeria: a paradigm swing? Ecancermedicalscience 14:1013. |
|
Esther SH, Hajo Z, Michael HR (2006). Albinism in Africa as a Public health issue. BMC Public Health 6(1):212. |
|
Fukuda N, Naito S, Masukawa D, Kaneda M, Miyamoto H, Abe T, Yamashita Y, Endo I, Nakamura F, Goshima Y (2015). Expression of ocular albinism 1 (OA1), 3, 4- dihydroxy- L phenylalanine (DOPA) receptor, in both neuronal and non-neuronal organs. Brain Research 1602:62-74. |
|
Inagaki K, Suzuki T, Shimizu H, Ishii N, Umezawa Y, Tada J, Kikuchi N, Takata M, Takamori K, Kishibe M, Tanaka M, Miyamura Y, Ito S, Tomita Y (2004). Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan. American Journal of Human Genetics 74:466-471. |
|
Juan AG (2021). Comparative transcriptomics of albino and warningly-coloured caterpillars. Ecology and Evolution 11(12):7507-7517. |
|
Kanski JJ (2016). Clinical ophthalmology. 8th edition. Butterworth Heinemann, Oxford 668 p. |
|
Karen G, Jakob Ek, Karen BN (2007). Oculocutaneous albinism. Orphanet Journal of Rare Diseases 2(1):1-8. |
|
Khanal S, Pokharel A, Kandel H (2016). Visual deficits in Nepalese patients with oculocutaneous albinism. Journal of Optometry 9(2):102-9. |
|
Kubasch AS, Meurer M (2017). Oculocutaneous and ocular albinism. Hautarzt 68(11):867-875. |
|
Lee SY, Lee EJ, Byun JC, Jang KM, Kim SY, Hwang SK (2021). A new type of oculocutaneous albinism with a novel OCA2 mutation. Yeungnam University Journal of Medicine 8(2):160-164. |
|
Liqin J, Sen Z, Rongfang C, Li M, Xiaojun W, Yingying W, Jia Q, Xiangtian Z (2018). Effects of the Tyrosinase-Dependent Dopaminergic System on Refractive Error Development in Guinea Pigs. Investigative Ophthalmology and Visual Science 59:4631-4638. |
|
Marçon CR, Maia M (2019). Albinism: epidemiology, genetics, cutaneous characterization, psychosocial factors. Anais Brasileiros de Dermatologia 94(5):503-520. |
|
McKay BS (2019). Pigmentation and vision: Is GPR143 in control? Journal of Neuroscience Research 97(1):77-87. |
|
Newton JM, Cohen-Barak O, Hagiwara N, Gardner JM, Davisson MT, King RA, Brilliant MH (2001). Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4. American Journal of Human Genetics 69:981-988. |
|
Patel N, Bhadarka HK, Vaniawala S, Patel A (2020). A Successful Case for Deselection of Albino Embryo and Live Birth of Albinism-Free Healthy Baby Followed by PGT-M. Journal of Human Reproductive Sciences 13(3):245-248. |
|
Pillay E, Naidoo T, Asmal K, Maliwa L, Mchunua S, van Staden DB, Rampersad N (2021). Characterization of Retinal Thickness in Individuals with Albinism: Baseline Data for a Black South African Population. Clinical Optometry 13:15-22. |
|
Puzniak RJ, Ahmadi K, Kaufmann J, Gouws A, Morland AB, Pestilli F, Hoffmann MB (2019). Quantifying nerve decussation abnormalities in the optic chiasm. Neuroimage Clinical 24:102055. |
|
Rooryck C, Roudaut C, Robine E, Müsebeck J, Arveiler B (2006). Oculocutaneous albinism with TYRP1 gene mutations in a Caucasian patient. Pigment Cell and Melanoma Research 19:239-240. |
|
Rothammer S, Kunz E, Seichter D, Krebs S, Wassertheurer M, Fries R, Brem G, Medugorac I (2017). Detection of two non-synonymous SNPs in SLC45A2 on BTA20 as candidate causal mutations for oculocutaneous albinism in Braunvieh cattle. Genetics Selection Evolution 49(1):73. |
|
Rymer J, Choh V, Bharadwaj S, Padmanabhan V, Modilevsky L, Jovanovich E, Yeh B, Zhang Z, Guan H, Payne W, Wildsoet CF (2007). The albino chick as a model for studying ocular developmental anomalies, including refractive errors, associated with albinism. Experimental Eye Research 85(4):431-442. |
|
Sajid Z, Yousaf S, Waryah YM, Mughal TA, Kausar T, Shahzad M, Rao AR, Abbasi AA, Shaikh RS, Waryah AM, Riazuddin S, Ahmed ZM (2021). Genetic Causes of Oculocutaneous Albinism in Pakistani Population. Genes 12(4):492. |
|
Saka B, Teclessou JN, Akakpo SA, Gnossike P, Doh K, Adam S, Mouhari-Toure A, Mahamadou G, Kassang P, Elegbede Moise Y, Darre T, Kombate K, Pitché P (2020). A Histopathological Study of Skin Lesions in Individuals with Oculocutaneous Albinism in Togo in 2019. Journal of Skin Cancer 2361957. |
|
Sani RY, Hassan S, Habib SG, Ifeanyichukwu EP (2016). Cycloplegic effect of atropine compared with cyclopentolate-tropicamide combination in children with hypermetropia. Niger Medical Journal, 57:173-7. |
|
Sayed KM, Mahmoud AM, Gad KA (2021). Analysis of the Refractive Profile of Children with Oculocutaneous Albinism versus an Age-Matched Non-Albino Group. Clinical Ophthalmology 15:73-78. |
|
Schidlowski L, Liebert F, Iankilevich PG, Rebellato PRO, Rocha RA, Almeida NAP, Jain A, Wu Y, Itan Y, Rosati R, Prando C (2020). Non-syndromic Oculocutaneous Albinism: Novel Genetic Variants and Clinical Follow Up of a Brazilian Pediatric Cohort. Frontiers in Genetics 11:397. |
|
Schulze SM, Kumar N, Bohrmann D, Msukwa G, Kalua K, Kayange P, Spitzer MS (2015). Refractive errors, visual impairment, and the use of low-vision devices in albinism in Malawi. Graefe's Archive for Clinical and Experimental Ophthalmology 253(4):655-661. |
|
Shah M, Khan MT, Saeed N (2020). Visual rehabilitation of people with oculocutaneous albinism in a tertiary clinical setting in Pakistan. Saudi Journal of Ophthalmology 34(2):111-115. |
|
Suzuki T, Tomita Y (2008). Recent advances in genetic analyses of oculocutaneous albinism types 2 and 4. Journal of Dermatological Science 51:1-9. |
|
Udeh NN, Eze BI, Onwubiko SN, Arinze OC, Onwasigwe EN, Umeh RE (2014). Prevalence and profile of ophthalmic disorders in oculocutaneous albinism: a field report from South-Eastern Nigeria. Journal of Community Health 39(6):1193-1199. |
|
Woertz EN, Omoba BS, Dunn TM, Chiu SJ, Farsiu S, Strul S, Summers CG, Drack AV, Carroll J (2020). Assessing Ganglion Cell Layer Topography in Human Albinism Using Optical Coherence Tomography. Investigative Ophthalmology and Visual Science 61(3):36. |
|
Wright CY, Norval M, Hertle RW (2015). Oculocutaneous albinism in sub-Saharan Africa: adverse sun-associated health effects and photoprotection. Photochem Photobiol 91(1):27-32. |
|
Wu KC, Lv JN, Yang H, Yang FM, Lin R, Lin Q, Shen RJ, Wang JB, Duan WH, Hu M, Zhang J, He ZL, Jin ZB (2020). Nonhuman Primate Model of Oculocutaneous Albinism with TYR and OCA2 Mutations. Research Washinton DC. 2020:1658678. |
|
Zhong Z, Gu L, Zheng X, Ma N, Wu Z, Duan J, Zhang J, Chen J (2019). Comprehensive analysis of spectral distribution of a large cohort of Chinese patients with non-syndromic oculocutaneous albinism facilitates genetic diagnosis. Pigment Cell and Melanoma Research 32(5):672-686. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0